This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (28)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Dan Douer, MD; Abraham Weinberger, MD; Jack Pinkhas, MD; Abraham Atsmon, MD, PhD

JAMA. 1978;240(8):766-768.

Abstract
A patient had an acute attack of intermittent porphyria with severe neurologic manifestations, hypertension, and tachycardia. Treatment with propranolol hydrochloride (Deralin [Israel]; Inderal, comparable US product) intravenously administered in a total dose of 284 mg during a period of 18 hours, was followed by clinical remission associated with a decline in urinary excretion of porphyrin precursors.

(JAMA 240:766-768, 1978)

Author Affiliations
From the Department of Internal Medicine D (Drs Douer, Pinkhas, and Weinberger) and the Laboratory of Biochemical Pharmacology (Dr Atsmon), Beilinson Medical Center, Petah Tiqva, Israel, and Tel Aviv University Medical School (Drs Douer, Weinberger, Pinkhas, and Atsmon), Ramat Aviv, Israel.

Footnotes
Reprint requests to Department of Internal Medicine D, Beilinson Hospital, Petah Tiqva, Israel (Dr Pinkhas).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Juvenile Acute Intermittent Porphyria With Hypercholesterolemia and Epilepsy: A Case Report and Review of the Literature
Kaplan and Lewis
J Child Neurol 1986;1:38-45.
ABSTRACT